CT Clinical Research
CT Clinical Research
  • Home
  • About Us
  • Studies
    • List of All Studies
    • Results and Publications
  • Participants
    • About Clinical Trials
    • What to Expect
    • FAQs
  • Sponsors
  • Contact Us
  • More
    • Home
    • About Us
    • Studies
      • List of All Studies
      • Results and Publications
    • Participants
      • About Clinical Trials
      • What to Expect
      • FAQs
    • Sponsors
    • Contact Us
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out


Signed in as:

filler@godaddy.com

  • Home
  • About Us
  • Studies
    • List of All Studies
    • Results and Publications
  • Participants
    • About Clinical Trials
    • What to Expect
    • FAQs
  • Sponsors
  • Contact Us

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

Binge Eating Disorder

 

About This Study

The Axsome SOL-BED-301 Study is looking at how well an investigational study drug works for people living with Binge Eating Disorder (BED).


Binge eating disorder is characterized by recurrent episodes of binge eating, which include:

  • Eating within a discrete period of time (e.g., within any 2-hour period), an amount of food that is definitely larger than what most people would eat in a similar period of time under similar circumstances
  • A sense of lack of control over one’s eating during the episode (e.g., a feeling that one cannot stop eating or control what or how much one is eating)


In this study, doctors want to evaluate the safety and effectiveness of an oral investigational drug. Researchers want to compare the investigational drug to placebo, which looks like the investigational drug but contains no active medication. 


The investigational drug is not approved to treat BED. You may not directly benefit from participating in this study. However, the results of this study will provide more information about the investigational drug and whether it could one day be approved to treat BED.


Clinical Trials Listing: https://clinicaltrials.gov/study/NCT06413433

Interested in Participating?

Sign Up

What Will Happen During This Study?

This study is being carried out to:

  • see how well the study drug works for people living with BED
  • confirm how safe the study drug is


If you take part, you will:

  • be in the study for up to 18 weeks
  • visit the study center up to 10 times
  • take either the study drug or placebo (both referred to as the “study medication” – a placebo looks the same as the study drug but contains no active medication)
  • continue to take your usual medications

What Can You Expect From This Study?

It’s possible you could benefit from study participation, but this cannot be guaranteed. However, your study participation could help people with BED in the future. 


You may also experience one or more side effects during this study. Prior to you beginning study participation, the study staff will review known study-related risks and side effects with you. 


Throughout the study, you will be closely monitored for any study-related side effects or changes in your health. 

Who is eligible to participate in this study?

Key Entry Criteria:

  • Are between 18 and 55 years of age 
  • Have experienced at least 2 binge episodes per week over the last 6 months
  • Currently experiencing symptoms of Binge Eating Disorder (BED) such as recurrent episodes of consuming excessive amounts of food accompanied by a sense of loss of control over the eating 


​Additional criteria will apply. All study-related visits, tests, and drugs will be provided at no cost. You may also be reimbursed for study-related travel expenses. 

​
Please complete the form below, and a member of our study team will reach out to you.

 160 West Street Suite 1A | Cromwell, CT 06416 | Phone: (860) 632-0144 | Copyright © 2024 CT Clinical Research - All Rights Reserved

  • Terms & Conditions
  • Privacy Policy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept